1. Home
  2. CAAS vs KRRO Comparison

CAAS vs KRRO Comparison

Compare CAAS & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.44

Market Cap

128.8M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$12.84

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
KRRO
Founded
N/A
2014
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.8M
150.0M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
CAAS
KRRO
Price
$4.44
$12.84
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
25.7K
154.2K
Earning Date
04-22-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
181.46
52 Week Low
$3.80
$5.20
52 Week High
$5.15
$55.89

Technical Indicators

Market Signals
Indicator
CAAS
KRRO
Relative Strength Index (RSI) 57.59 49.25
Support Level $4.12 $12.51
Resistance Level $4.61 $14.76
Average True Range (ATR) 0.12 0.76
MACD 0.03 -0.16
Stochastic Oscillator 65.85 16.63

Price Performance

Historical Comparison
CAAS
KRRO

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: